Adverse Event Reporting: The 48-Hour, 10-Day and 30-Day Deadlines

1. Key takeaways

Medical device adverse event reporting in the Philippines uses three tiers: serious public health threat → within 48 hours; death or serious deterioration in health → within 10 days; where recurrence could lead to death or serious deterioration in health → within 30 calendar days. The clock starts when any personnel within the organisation becomes aware of the event, including sales representatives. After the initial report, a final investigation report must be submitted within 30 days.

• Three deadlines, one decision rule. The tier is chosen by consequence, not by event type.
• The clock starts at awareness, not at internal confirmation. Awareness held by a field representative starts the countdown for the whole company.
• Reportability requires three conditions to hold at once: an adverse event occurred, the device is associated with it, and the consequence is a serious public health threat, serious deterioration in health or death.
• Where the assessment is uncertain, the framework leans towards reporting.
• Distributors must forward complaints or adverse event information to the MAH within 14 calendar days.

2. Legal basis

The reporting architecture comes from Annex 5 of the AMDD as implemented by AO No. 2025-0030. The table below sets out the deadlines, the trigger and the decision criteria that determine whether a report is required.

3. Expert insights

Insight 1: the tier is determined by the consequence, not by the event type.

Many companies look up the table by event type (device malfunction, use error) and then look for a deadline. That is the wrong path. The correct sequence is to first determine which consequence tier applies (serious public health threat, death or serious deterioration, or risk of recurrence), and only then apply the deadline. The same category of event can fall into tiers whose deadlines differ by a factor of 30 depending on the consequence. Building an internal matrix organised by event type therefore produces confident but wrong answers, because the matrix encodes the wrong question.

Insight 2: the clock starts when any personnel becomes aware, and this is the most commonly underestimated rule.

The rule is explicit: timing starts when any personnel within the organisation becomes aware, including sales representatives. If a sales representative hears about an event during a hospital visit, the 48-hour or 10-day clock has started, even if the regulatory department only learns of it three days later. GRZAN’s approach is to write awareness-plus-escalation into an all-staff SOP covering sales, marketing and customer service roles, and to fix an internal handover deadline (for example, 4 hours). The SOP is not a substitute for the regulatory rule; it is the only way the regulatory rule can be met.

Insight 3: compared with other markets, the Philippine deadlines align with Singapore.

Viewed across the region, the Philippines (48 hours / 10 days / 30 days) is broadly consistent with Singapore (48 hours / 10 calendar days / 30 calendar days), which reflects the shared ASEAN adoption of the AMDD. For companies operating in several countries this is good news: one vigilance SOP can cover both the Philippine and Singapore markets, with local adaptation limited to the reporting channel and the form format. The alignment also means that a regional template can be maintained centrally, rather than rebuilt for each market.

Insight 4: leaning towards reporting is a protective rule.

AO No. 2025-0030 states that where it is unclear whether the reporting criteria are met, policy leans towards reporting. This is the other side of the rule that deliberate failure to report, or deliberate concealment of information, will be treated more severely. For companies, the safest posture is not precision in classification but treating borderline cases as reportable — the cost of an unnecessary report is far lower than the cost of a missed one.

4. Practical recommendations

• Write awareness-plus-escalation into an all-staff SOP. Cover every outward-facing role: sales, marketing, customer service and technical support. Name the person who receives the notification and the channel used.
• Set an internal handover deadline (for example, 4 hours). This leaves the regulatory function time to assess the case before the external deadline bites.
• Treat borderline cases as reportable. Do not build a culture in which the default answer is to wait for certainty.
• Define a separate IVD assessment standard. It must cover indirect harm scenarios, including wrong results that lead to delayed or incorrect treatment.
• Maintain a reporting register. Record the date of awareness, the date of report, the report reference number and the date of the final report for every case, so that the clock can be reconstructed after the fact.

5. Verification checklist

• □ Three-tier deadlines confirmed (48 hours / 10 days / 30 days)
• □ Clock start defined as awareness by any personnel, including sales representatives
• □ Final report deadline confirmed as 30 days after the initial report
• □ All-staff SOP covers outward-facing roles
• □ IVD indirect harm criterion defined in the SOP
• □ Distributor 14-day handover written into distribution agreements
• □ Reporting register captures the four dates for each case

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including the Philippines. Our team prepares CMDN/CMDR dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the FDA Philippines, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com